Should New Zealand continue signing up to the Pethidine Protocol?

New Zealand Medical Journal

Volumn 119, Issue 1230, 2006, Pages

  Shipton, Edward A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ATROPINE; BUPIVACAINE; CLONIDINE; DEXTROMETHORPHAN; DEXTROPROPOXYPHENE; FENTANYL; GLYCOPYRRONIUM BROMIDE; LEVOBUPIVACAINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHADONE; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORPETHIDINE; PENTAZOCINE; PETHIDINE; PLACEBO; PROMETHAZINE; REMIFENTANIL; ROPIVACAINE; SEROTONIN UPTAKE INHIBITOR; SUFENTANIL; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGITATION; ANALGESIC ACTIVITY; ANXIETY DISORDER; ATAXIA; BILIARY COLIC; BILIARY TRACT DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONVULSION; DELIRIUM; DIAPHORESIS; DIARRHEA; DIZZINESS; DROWSINESS; DRUG ABUSE; DRUG BIOAVAILABILITY; DRUG DEPENDENCE; DRUG HALF LIFE; DRUG METABOLISM; DRUG USE; ERYTHEMA; EVIDENCE BASED MEDICINE; FEVER; HALLUCINATION; HEALTH CARE SYSTEM; HEART ARRHYTHMIA; HUMAN; HYPERREFLEXIA; HYPOTENSION; IRRITABILITY; KIDNEY COLIC; LABOR PAIN; MUSCLE SPASM; MUSCLE TWITCH; MYOCLONUS; NAUSEA; NERVOUSNESS; NEW ZEALAND; PANCREATITIS; PARKINSONISM; PHYSICIAN; POSTOPERATIVE PAIN; RESPIRATION DEPRESSION; RESTLESSNESS; REVIEW; SEIZURE; SEROTONIN SYNDROME; SHIVERING; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; TREMOR; URINE RETENTION; VOMITING; COST BENEFIT ANALYSIS; DRUG CONTROL; DRUG INTERACTION; DRUG SCREENING; ECONOMICS; FEMALE; METHODOLOGY; OPIATE ADDICTION; PAIN; PREGNANCY;

ANALGESICS, OPIOID; COST-BENEFIT ANALYSIS; DRUG AND NARCOTIC CONTROL; DRUG EVALUATION; DRUG INTERACTIONS; FEMALE; HUMANS; MEPERIDINE; NEW ZEALAND; OPIOID-RELATED DISORDERS; PAIN; PREGNANCY;

EID: 33645216342     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Clark RF, Wei EM, Anderson PO. Meperidine: therapeutic use and toxicity. J Emerg Med. 1995;13:797-802.
2. Quaglia MG, Farina A, Donati E, et al. Determination of MPTP, a toxic impurity of pethidine. J Pharm Biomed Anal. 2003;33:1-6.
3. Lee K, Ho KM. Obstetric regional analgesia services in New Zealand: a national survey. N Z Med J. 2004;117(1206).URL: http://www.nzma.org.nz/journal/117-1206/1177.
4. Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther. 2002;9:53-68.
5. Wacker MS, Moniz CJ. Meperidine: second-line agent with first-line prescribing practices. Med Health R I. 2001;84:10-14.
6. Kredo T, Onia R. Pethidine - does familiarity or evidence perpetuate its use? S Afr Med J. 2005;95:100-1.
7. Smith LA, Carroll D, Edwards JE, et al. Single-dose ketorolac and pethidine in acute postoperative pain: systematic review with meta-analysis. Br J Anaesth. 2000;84:48-58.
8. Shipton E. Predictors of persistent acute postoperative pain: an opportunity for preventative medicine to reduce the burden of chronic pain. N Z Med J. 2005;118 (1208). URL: http://www.nzma.org.nz/journal/118-1208/1261.
9. Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol. 2001;96:1266-72.
10. Hubbard GP, Wolfe KR. Meperidine misuse in a patient with sphincter of Oddi dysfunction. Ann Pharmacother. 2003;37:534-7.
11. Dula DJ, Anderson R, Wood GC. A prospective study comparing i.m. ketorolac with i.m. meperidine in the treatment of acute biliary colic. J Emerg Med. 2001;20:121-4.
12. Henderson SO, Swadron S, Newton E. Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic. J Emerg Med. 2002;23:237-41.
13. O'Connor A, Schug SA, Cardwell H. A comparison of the efficacy and safety of morphine and pethidine as analgesia for suspected renal colic in the emergency setting. J Accid Emerg Med. 2000;17:261-4.
14. Holdgate A, Pollock T. Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic. Cochrane Database Syst Rev. 2004;(1):CD004137.
15. Laerum E, Murtagh J. Renal colic and recurrent urinary calculi. Management and prevention. Aust Fam Physician. 2001;30:36-41.
16. Sosa CG, Balaguer E, Alonso JG, et al. Meperidine for dystocia during the first stage of labor: A randomized controlled trial. Am J Obstet Gynecol. 2004;191:1212-8.
17. Bricker L, Lavender T. Parenteral opioids for labor pain relief: a systematic review. Am J Obstet Gynecol. 2002;186(Suppl 5 Nature):S94-109.
18. Soontrapa S, Somboonporn W, Komwilaisak R, Sookpanya S. Effectiveness of intravenous meperidine for pain relief in the first stage of labour. J Med Assoc Thai. 2002;85:1169-75.
19. Mattingly JE, D'Alessio J, Ramanathan J. Effects of obstetric analgesics and anesthetics on the neonate: a review. Paediatr Drugs. 2003;5:615-27.
20. Solt I, Ganadry S, Weiner Z. The effect of meperidine and promethazine on fetal heart rate indices during the active phase of labor. Isr Med Assoc J. 2002;4:178-80.
21. Matheson I, Nylander G. Should pethidine still be administered to women in labor? Tidsskr Nor Laegeforen. 1999;119:234-6.
22. Wong CA, Scavone BM, Peaceman AM, et al. The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. N Engl J Med. 2005;352:655-65.
23. Camorcia M, Capogna G, Columb MO. Minimum local analgesic doses of ropivacaine, levobupivacaine, and bupivacaine for intrathecal labor analgesia. Anesthesiology. 2005;102:646-50.
24. Siddik-Sayyid SM, Aouad MT, Jalbout MI, et al. Comparison of three modes of patient-controlled epidural analgesia during labour. Eur J Anaesthesiol. 2005;22:30-4.
25. Bar-Oz B, Bulkowstein M, Benyamini L, et al. Use of antibiotic and analgesic drugs during lactation. Drug Saf. 2003;26:925-35.
26. Volikas I, Butwick A, Wilkinson C, et al. Maternal and neonatal side-effects of remifentanil patient-controlled analgesia in labour. Br J Anaesth. 2005;95:504-9.
27. Spigset O, Hagg S. Analgesics and breast-feeding: safety considerations. Paediatr Drugs. 2000;2:223-38.
28. Golub MS. Labor analgesia and infant brain development. Pharmacol Biochem Behav. 1996;55:619-28.
29. Vranken JH, van der Vegt MH, van Kan HJ, Kruis MR. Plasma concentrations of meperidine and normeperidine following continuous intrathecal meperidine in patients with neuropathic cancer pain. Acta Anaesthesiol Scand. 2005;49:665-70.
30. Gordon DB, Jones HD, Goshman LM, et al. A quality improvement approach to reducing use of meperidine. Jt Comm J Qual Improv. 2000;26:686-99.
31. Shipton EA. Tramadol: a multimodal, multipurpose analgesic for the surgeon. S Afr J Surgery. 2003;41: 86-8.
32. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43:879-923.
33. Wagner LE 2nd, Eaton M, Sabnis SS, Gingrich KJ. Meperidine and lidocaine block of recombinant voltage-dependent Na+ channels: evidence that meperidine is a local anesthetic. Anesthesiology. 1999;91:1481-90.
34. Ngan Kee WD. Epidural pethidine: pharmacology and clinical experience. Anaesth Intensive Care. 1998;26:247-55.
35. Lorimer MR, Pedersen K, Lombard W. Optimal dosing interval for epidural pethidine after Caesarean section. Acute Pain. 2002;4:27-31.
36. Stephens MB, Ford RE. Intrathecal narcotics for labor analgesia. Am Fam Physician. 1997;56:463-70.
37. Ehikhametalor KO, Nelson M. Intrathecal pethidine as sole anaesthetic agent for operative procedures of the lower limb, inguinal area and perineum. West Indian Med J. 2001;50:313-6.
38. Urmey WF. Spinal anaesthesia for outpatient surgery. Best Pract Res Clin Anaesthesiol. 2003;17:335-46.
39. Roy JD, Girard M, Drolet P. Intrathecal meperidine decreases shivering during cesarean delivery under spinal anesthesia. Anesth Analg. 2004;98:230-4.
40. Kranke P, Eberhart LH, Roewer N, Tramer MR. Postoperative shivering in children: a review on pharmacologic prevention and treatment. Paediatr Drugs. 2003;5:373-83.
41. Bhatnagar S, Saxena A, Kannan TR, et al. Tramadol for postoperative shivering: a doubleblind comparison with pethidine. Anaesth Intensive Care. 2001;29:149-54.
42. Beckwith MC, Fox ER, Chandramouli J. Removing meperidine from the health-system formulary - frequently asked questions. J Pain Palliat Care Pharmacother. 2002;16:45-59.
43. Iles S, Catterall JR, Hanks G. Use of opioid analgesics in a patient with chronic abdominal pain. Int J Clin Pract. 2002;56:227-8.
44. Keskin HL, Keskin EA, Avsar AF, et al. Pethidine versus tramadol for pain relief during labor. Int J Gynaecol Obstet. 2003;82:11-6.
45. Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95:434-41.
46. Simopoulos TT, Smith HS, Peeters-Asdourian C, Stevens DS. Use of meperidine in patient-controlled analgesia and the development of a normeperidine toxic reaction. Arch Surg. 2002;137:84-8.
47. Hassan H, Bastani B, Gellens M. Successful treatment of normeperidine neurotoxicity by hemodialysis. Am J Kidney Dis. 2000;35:146-9.
48. Lotsch J. Opioid metabolites. J Pain Symptom Manage. 2005;29(Suppl 5):10-24.
49. van Voorthuizen T, Helmers JH, Tjoeng MM, Otten MH. Meperidine (pethidine) outdated as analgesic in acute pancreatitis. Ned Tijdschr Geneeskd. 2000;144:656-8.
50. Davies G, Kingswood C, Street M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet. 1996;31:410-22.
51. Seifert CF, Kennedy S. Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy. 2004;24:776-83.
52. Adunsky A, Levy R, Heim M, et al. Meperidine analgesia and delirium in aged hip fracture patients. Arch Gerontol Geriatr. 2002;35:253-9.
53. Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Saf. 1998;19:173-89.
54. Rautakorpi P, Manner T, Kanto J, Lertola K. Metabolic and clinical responses to different types of premedication in children. Paediatr Anaesth. 1999;9:387-92.
55. Sporer KA. The serotonin syndrome. Implicated drugs, pathophysiology and management. Drug Saf. 1995;13:94-104.
56. Bonnet U. Moclobemide: therapeutic use and clinical studies. CNS Drug Rev. 2003;9:97-140.
57. Hansen GR. The drug-seeking patient in the emergency room. Emerg Med Clin North Am. 2005;23:349-65.
58. Colman I, Rothney A, Wright SC, et al. Use of narcotic analgesics in the emergency department treatment of migraine headache. Neurology. 2004;62:1695-700.
59. Bateman C. The drug-addicted doctor - who dares to care? S Afr Med J. 2004;94:726-7.
60. Cadman M, Bell J. Doctors detected self-administering opioids in New South Wales, 1985-1994: characteristics and outcomes. Med J Aust. 1998;169:419-21.
61. Domino KB, Hornbein TF, Polissar NL, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA. 2005;293:1453-60.
62. Kintz P, Villain M, Dumestre V, Cirimele V. Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci Int. 2005;153:81-4.
63. Panda M, Desbiens N, Doshi N, Sheldon S. Determinants of prescribing meperidine compared to morphine in hospitalized patients. Pain. 2004;110:337-42.
64. Macintyre PE, Ready LB. Pharmacology of opioids. In: Acute pain management: a practical guide. Macintyre PE, Ready LB, editors. 1st ed. London: WB Saunders; 2001, p15-49.
65. Cepeda MS, Farrar JT, Baumgarten M, et al. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther. 2003;74:102-12.